Records containing: Previously Treated Myelodysplastic Syndromes

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2013-01-23
Phase I Study of PS-341 in Acute Myeloid Leukemias, Myelodysplastic Syndromes and Chronic Myeloid Leukemia in Blast Phase
CLINICAL_TRIALS study record update · 2013-01-23
Phase II Trial of Liposomal Daunorubicin (Daunoxome) and SU5416 (NSC 696819) in Patients With AML, RAEB, RAEB-T or CMML in Transformation Refractory to One Course of Induction Chemotherapy
CLINICAL_TRIALS study record update · 2013-01-11
Phase I and Pharmacodynamic Study of SB-715992 in Acute Leukemias
CLINICAL_TRIALS study record update · 2013-01-09
Dose Finding Study of Bryostatin-1 and GM-CSF in Refractory Myeloid Malignancies
CLINICAL_TRIALS study record update · 2013-01-07
A Phase I Trial of SAHA (NSC 701852) and Decitabine (IND 50733, NSC 127716) in Patients With Relapsed, Refractory or Poor Prognosis Leukemia
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2013-01-07
A Phase I/II Study of PR1 (NSC 698102) Human Leukemia Peptide Vaccine With Montanide ISA 51 (NSC 675756) or Montanide ISA 51 VG (NSC 737063) Adjuvant
CLINICAL_TRIALS study record update · 2012-07-09
Pilot Study of Mechanical Stimulation for Prevention of Hematopoietic Cell Transplant Associated Bone Density Loss
CLINICAL_TRIALS study record update · 2012-03-07
INSPIRE: An Internet-based RCT for Long-term Survivors of Hematopoietic Stem Cell Transplantation
CLINICAL_TRIALS study record update · 2010-08-09
High-dose Busulfan, High-dose Cyclophosphamide, and Allogeneic Bone Marrow Transplantation for Leukemia, Myelodysplastic Syndromes, Multiple Myeloma and Lymphoma